Vagus nerve stimulation (VNS) is a technology that provides electrical stimulation to the
cervical vagus nerve and can be applied in the treatment of a wide variety of …

Research conducted on individuals with depression reveals that major depressive disorders
(MDDs) coincide with diminished levels of the inhibitory neurotransmitter γ-aminobutyric …

Non-invasive transcutaneous vagus nerve stimulation elicits similar therapeutic effects as
invasive vagus nerve stimulation, offering a potential treatment alternative for a wide range …

Background: Status epilepticus is a life-threatening condition that is defined as refractory
(RSE) when the seizure activity continues despite treatment with benzodiazepine and a …

Vagus nerve stimulation (VNS) was the first device-based therapy for epilepsy, having
launched in 1994 in Europe and 1997 in the United States. Since then, significant advances …

In 2017, one of us reviewed advances in epilepsy (Manford in J Neurol 264: 1811–1824,
2017). The current paper brings that review up to date and gives a slight change in …

Chronic pain and depression are highly prevalent pathologies and cause a major
socioeconomic burden to society. Chronic pain affects the emotional state of the individuals …

The interaction between sleep and epilepsy is complex. A better understanding of the
mechanisms linking sleep and epilepsy appears increasingly important as it may improve …

Epilepsy is one of the most common neurological disorders, affecting over 65 million people
worldwide. Despite medical management with anti-seizure medications (ASMs), many …

Background Vagus nerve stimulation (VNS) has emerged as a promising therapeutic
approach for stroke treatment, drawing significant attention due to its potential benefits …